Who owns BIS?
ProShares UltraShort Nasdaq Biotechnology · ProShares
2 institutions reported holding BIS, worth $677K, in Form 13F filings for June 30, 2026.
Top 2 institutional holders of BIS
| Firm | Location | Value | Shares | Change |
|---|---|---|---|---|
| Susquehanna International Group, LLP | Bala Cynwyd, PA | $603K | 44,359 | New position |
| Tower Research Capital LLC (TRC) | New York, NY | $74K | 5,458 | New position |
From SEC Form 13F, for managers with $100M+ in US securities. Change compares June 30, 2026 with March 31, 2026. “New position” means no holding in the prior filing we have.
Similar ETFs
Compare what they hold: BIS vs PLTA, BIS vs BTCL, BIS vs SPOG, BIS vs UBEW.
Frequently asked questions
Who owns BIS?
2 institutional managers reported holding BIS in Form 13F filings for June 30, 2026, worth $677K in total. The largest reported position was held by Susquehanna International Group, LLP, at $603K.
What is a Form 13F?
A quarterly report filed with the SEC by institutional investment managers with $100 million or more in qualifying US securities. It lists their long positions at quarter end. It doesn't cover retail investors, cash, short positions, or managers under the threshold, so it shows part of a fund's ownership, not all of it.
How often is BIS ownership data updated?
13F filings are due 45 days after each quarter ends. The next set is due around mid-November. Positions can be up to about four and a half months old by the time a new set arrives.